is mounjaro glp 1 drug GLP-1 Drugs Mounjaro, Zepbound, Wegovy Back in Stock After Extended Shortages FAQ of the Month: Is

Regulatory Status and Absence of Human Safety Data As of 2026, retatrutide has not received approval from the MHRA, FDA, EMA, or any other regulatory authority for human use

Eleftheriadou A, Riley D, Zhao SS, et al

Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (surpass-3 MRI): A substudy of the randomised, open-label, parallel-group, phase 3 surpass-3 trial

How do these two behemoths fare when we compare their past performances from a fundamental perspective

GLP-1- based treatments for T2DM, such as GLP-1 receptor agonists, dual and triple agonists that activate GLP-1R, GIPR, and glucagon receptors, and dipeptidyl peptidase-4 (DPP-4) inhibitors have been reviewed here

A meta-analysis across multiple studies confirmed the pattern: tirzepatide produces roughly 4.23 kg (about 9.3 pounds) more weight loss than semaglutide on average